Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-04-28

FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ketorolac tromethamine from Hikma Pharmaceuticals USA Inc., updating the labeling of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)